Edition:
United States

Sequenom Inc (SQNM.OQ)

SQNM.OQ on NASDAQ Stock Exchange Global Select Market

2.36USD
29 Jul 2016
Change (% chg)

$-0.01 (-0.42%)
Prev Close
$2.37
Open
$2.36
Day's High
$2.37
Day's Low
$2.36
Volume
232,176
Avg. Vol
286,395
52-wk High
$2.96
52-wk Low
$0.82

Select another date:

Thu, Jul 28 2016

BRIEF-Sequenom cancels Q2 results conf call

* Sequenom announces cancellation of second quarter 2016 results conference call Source text for Eikon: Further company coverage: (Bengaluru Newsroom +1-646-223-8780)

Diagnostics company LabCorp to buy smaller rival Sequenom

Laboratory Corporation of America Holdings said it would buy Sequenom Inc , a maker of non-invasive prenatal tests for reproductive health, for about $371 million, including debt.

Diagnostics company LabCorp to buy smaller rival Sequenom

July 27 Laboratory Corporation of America Holdings said it would buy Sequenom Inc, a maker of non-invasive prenatal tests for reproductive health, for about $371 million, including debt.

UPDATE 2-U.S. Supreme Court refuses to review prenatal test patent dispute

NEW YORK, June 27 The U.S. Supreme Court on Monday rejected a bid to review a legal fight over the cancellation of a patent on a less-risky form of prenatal testing, in a case that has left many companies and trade groups worried that important discoveries may no longer qualify for patents.

BRIEF-Sequenom files patent infringement lawsuit in Australia

* Patent relates to detection of cell-free fetal DNA for non-invasive prenatal testing (NIPT)

Roche tells Supreme Court no need to revisit Sequenom patent invalidation

Roche Holding AG has urged the U.S. Supreme Court not to overturn the precedents it has carefully developed over decades barring patents on natural laws and phenomena in response to a plea from Sequenom, Inc to save a patent on its prenatal DNA test from invalidation.

BRIEF-Sequenom Inc reports Q1 loss per share $0.11

* Q1 earnings per share view $-0.10 -- Thomson Reuters I/B/E/S

BRIEF-Sequenom announces in-network contracts with Anthem Blue Cross, Blue Shield

* Announces in-network contracts with Anthem Blue Cross, Blue Shield plans for Georgia, Indiana, Kentucky, Missouri, Ohio, Virginia, Wisconsin Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

BRIEF-Sequenom sees net cash costs about $1 mln in Q1 of 2016

* Sequenom completes consolidation of North Carolina operations

BRIEF-Camber Capital reports 14.54% stake in Sequenom Inc

March 24 Camber Capital Management LLC Reports 14.54% Stake In Sequenom Inc As Of March 23, 2016

Select another date: